These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 11547915

  • 21. [Insulin signal transduction disorder and development of insulin resistance].
    Huang DM, Lu FE.
    Sheng Li Ke Xue Jin Zhan; 2003 Jul; 34(3):212-6. PubMed ID: 14628465
    [Abstract] [Full Text] [Related]

  • 22. Inositol phosphoglycan P-type in healthy and preeclamptic pregnancies.
    Scioscia M, Gumaa K, Whitten M, Selvaggi LE, Rodeck CH, Rademacher TW.
    J Reprod Immunol; 2007 Dec; 76(1-2):85-90. PubMed ID: 17493685
    [Abstract] [Full Text] [Related]

  • 23. Resistance to insulin.
    Muşeţeanu P, Oprescu S.
    Endocrinologie; 1988 Dec; 26(3):221-6. PubMed ID: 3062758
    [No Abstract] [Full Text] [Related]

  • 24. IRS2 takes center stage in the development of type 2 diabetes.
    Brady MJ.
    J Clin Invest; 2004 Oct; 114(7):886-8. PubMed ID: 15467824
    [Abstract] [Full Text] [Related]

  • 25. Hypoglycemic effect of Astragalus polysaccharide and its effect on PTP1B.
    Wu Y, Ou-Yang JP, Wu K, Wang Y, Zhou YF, Wen CY.
    Acta Pharmacol Sin; 2005 Mar; 26(3):345-52. PubMed ID: 15715932
    [Abstract] [Full Text] [Related]

  • 26. [Insulin signaling and insulin resistance].
    Ferré P.
    Therapie; 2007 Mar; 62(4):277-84. PubMed ID: 17983553
    [Abstract] [Full Text] [Related]

  • 27. D-chiro inositol phosphoglycans in preeclampsia: Where are we, where are we going?
    Scioscia M.
    J Reprod Immunol; 2017 Nov; 124():1-7. PubMed ID: 28982033
    [Abstract] [Full Text] [Related]

  • 28. Design and synthesis of inositolphosphoglycan putative insulin mediators.
    López-Prados J, Cuevas F, Reichardt NC, de Paz JL, Morales EQ, Martín-Lomas M.
    Org Biomol Chem; 2005 Mar 07; 3(5):764-86. PubMed ID: 15731862
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. GLP-1 effect upon the GPI/IPG system in adipocytes and hepatocytes from diabetic rats.
    Márquez L, González N, Puente J, Valverde L, Villanueva-Peñacarrillo ML.
    Diabetes Nutr Metab; 2001 Oct 07; 14(5):239-44. PubMed ID: 11806463
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Diabetes, obesity, and the brain.
    Schwartz MW, Porte D.
    Science; 2005 Jan 21; 307(5708):375-9. PubMed ID: 15662002
    [Abstract] [Full Text] [Related]

  • 33. [Alterations of expression of G protein-inositol phosphates pathway-related genes in essential hypertension: experiment with spontaneously hypertensive rats].
    Chen NY, Hu SJ, Dong HT, Li DB, Chen ZK.
    Zhonghua Yi Xue Za Zhi; 2005 Dec 28; 85(49):3481-5. PubMed ID: 16686064
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Regulation of insulin receptor function in microdomains].
    Inokuchi J, Kabayama K, Nagafuku M, Sato T.
    Tanpakushitsu Kakusan Koso; 2008 Sep 28; 53(12 Suppl):1552-7. PubMed ID: 21089365
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Nitric oxide and vascular insulin resistance.
    Wu G, Meininger CJ.
    Biofactors; 2009 Sep 28; 35(1):21-7. PubMed ID: 19319842
    [Abstract] [Full Text] [Related]

  • 38. Intracellular mediators of insulin action.
    Cheng K, Larner J.
    Annu Rev Physiol; 1985 Sep 28; 47():405-24. PubMed ID: 2986536
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.